Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02174003 · ClinicalTrials.gov registry record

Whole Body Hyperthermia Registry Study

A clinical trial, sponsored by University of Arizona.

Terminated
Registry status
2
Enrollment target

NCT02174003: Clinical Trial study, sponsored by University of Arizona.

NCT02174003 is a clinical trial that was terminated before completion, run by University of Arizona. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02174003 was terminated before completion, sponsored by University of Arizona.

TERMINATED
Registry status
2 participants
Enrollment target

Study Summary

This protocol will allow for the implementation of a research registry pertaining to Whole Body Hyperthermia (WBH) use in various subject populations. The primary objective of the proposed study is to determine if WBH can have beneficial effects in various subject populations currently experiencing numerous other comorbidities, and the duration of the effect(s). This protocol is intended to become a secondary resort for individual's interested in receiving a Hyperthermia treatment for potential beneficial gain related to symptoms stemming from comorbidities other than depression (i.e. Fibromyalgia, Perimenopausal symptoms, arthritis, etc). Due to the fact that no external research funding has been acquired for this broad application this protocol is intended to charge a fee for cost covering purposes only. The registry trial will not be limited to only include individuals with major depressive disorder, however, this protocol will allow for an expanded use in all populations (while still excluding subjects based on safety parameters). We will monitor subject's physiological and clinical outcomes (if applicable) from a single Whole Body Hyperthermia treatment in an open fashion (no placebo/control condition). This registry study will include safety assessments 5 days prior to WBH, the day of WBH and 1 week following WBH.

Primary Outcome

Percent change in scores between baseline and subsequent assessments will be assessed

Interventions

  • DEVICE High intensity whole-body infrared heating

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2014-06
Est. Completion 2016-08
University of Arizona

349 total trials

Why NCT02174003 stopped before completion

NCT02174003 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which High intensity whole-body infrared heating is the first listed.

NCT02174003 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02174003 about?

NCT02174003 is a clinical study titled "Whole Body Hyperthermia Registry Study". This protocol will allow for the implementation of a research registry pertaining to Whole Body Hyperthermia (WBH) use in various subject populations. The primary objective of the proposed study is to determine if WBH can have beneficial effects in various subject populations currently experiencing ...

What is the current status of trial NCT02174003?

This trial is currently terminated. The enrollment target is 2 participants. The study started on 2014-06. Estimated completion is 2016-08.

What interventions are being tested in trial NCT02174003?

The interventions under investigation include: High intensity whole-body infrared heating (DEVICE).

Who is sponsoring clinical trial NCT02174003?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02174003, the US trial registry maintained by the National Library of Medicine. NCT02174003 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.